2015, 2016 &  2017 PRESENTERS





OpGen, Inc., (NASDAQ: OPGN) at the Boca Raton Country Club
​on Wednesday, February 15, 2017 

COMPANY OVERVIEW:
Complete Solutions for Microbial Genetic Analysis - OpGen, Inc. is harnessing the power of informatics and genomic analysis to provide complete solutions for patient, hospital and network-wide infection prevention and treatment. OpGen is dedicated to positively influencing individual healthcare outcomes, enhancing public health, and advancing scientific research by delivering precise, actionable information and results. We offer comprehensive multi-parameter screening and surveillance panels to combat current and emerging multi-drug resistant organisms (MDRO) including carbapenem resistant enterobacteriaceae (CRE) with the next generation of diagnostic and epidemiologic solutions. Learn more at www.opgen.com. OpGen, Acuitas MDRO, Acuitas Lighthouse and QuickFISH are registered trademarks of OpGen, Inc.

ABOUT YOUR PRESENTER 
Timothy Dec, CFO. Mr. Dec, has more than 20 years of public company financial leadership experience in technology and healthcare companies. He has served in chief financial officer or other senior financial executive roles at companies in a number of industries, including three publicly traded companies listed on NASDAQ or AMEX, such as Corvis Corporation, and at private equity-backed companies. Prior to joining OpGen, Mr. Dec served as Senior Vice President and Chief Financial Officer for Clubwidesports, LLC, a start-up sports management software company, from January 2014 to April 2015. From August 2007 to December 2012,
He was Senior Vice President and Chief Financial Officer of Fortress International Group, Inc., a publicly traded company. Mr. Dec also has public accounting firm experience. He is an adjunct professor at
Mount St. Mary’s University in Emmitsburg, Maryland, where he teaches M.B.A. courses in Finance. Mr. Dec holds a B.S. in accounting from Mount Saint Mary’s University, and an M.B.A. from American University
in Washington, DC.

________________________________________________

OWC Pharmaceuticals Research Corp. (OTCQB: OWCP) presented
at the Boca Raton Country Club on Wednesday, February 1, 2017

COMPANY OVERVIEW:
OWC Pharmaceutical Research Corp. [OTCQB: OWCP] is engaged in the business, through its wholly-owned Israeli subsidiary, One World Cannabis Ltd., of conducting medical research and clinical trials, in full compliance with all international regulatory protocols, for the development of cannabis-based products and treatments specifically designed for Multiple Myeloma, Psoriasis, Fibromyalgia, PTSD, Migraines, and unique delivery systems. These include a Cannabis Sublingual Tablet and a Cannabis Based Psoriasis Topical Cream.

ABOUT YOUR PRESENTER:
Ziv Turner, VP Sales and Business Development OWC Pharmaceutical Research Corp and Managing Director of One World Cannabis Ltd. 
Mr. Turner is a proven entrepreneur with extensive business development expertise, as well as significant experience within the international business community. A successful engineer, Mr. Turner has 20 years’ experience working in senior management positions for leading 
telecom companies.

Beginning 1995, he was head of sales for various leaders in the telecommunication industry. His responsibilities included establishing turnkey operating profit centers with regional partners, negotiating with local governments in the APAC countries, establishing OEM, and other partnerships with global integrators and distributors, and implementing regional sales and training programs. Mr. Turner is also the founder of Vocavu, an internet content company.




2014 presenters/Sponsored meetings

                               

December 10, 2014 - ATOSSA Genetics, Inc.
Atossa Genetics, Inc. (NASDAQ: ATOS) offered an informative and impressive presentation at The Stock & Bond Club. Here is some information on the company: Atossa Genetics is passionate about improving breast health and the overall well-being and health of women with whom we are associated with globally. Our focus has been and will continue to be on maintaining our position through the development of a suite of medical devices, therapeutics and laboratory developed procedures (LDPs) in those areas where we can make a difference in health, education and our community with respect to breast health. Visit www.atossagenetics.com




December 3, 2014 - PLURISTEM THERAPEUTICS
Pluristem Therapeutics - (NASDAQ: PSTI) Presented before The Stock & Bond Club. COMPANY OVERVIEW: Pluristem Therapeutics Inc. is a clinical-stage biotechnology company using placental cells and a unique, proprietary, three-dimensional (3D) technology platform to develop cell therapies for a broad spectrum of diseases. Pluristem derives its cell products from human placental cells. These cells are converted into PLacental eXpanded (PLX) cells, which secrete therapeutic proteins in response to signals produced by damaged tissues. Pluristem’s pipeline targets multiple indications involving inflammation and ischemia, including peripheral artery disease, muscle injury, preeclampsia, and graft versus host disease. PLX cells require no tissue matching prior to administration, making them an “off-the-shelf” product. The company’s GMP-certified in-house manufacturing facilities allow it to efficiently produce commercial quantities of homogeneous, clinical-grade PLX cells. Pluristem is currently the only company manufacturing large quantities of placenta-based cell products using a 3D bioreactor. Driving these development efforts is a management team dedicated to shaping the future of the company and of placenta-based cell therapies. The Pluristem team has many decades of industry and research experience and draws on this as it continues to progress towards company goals. http://www.pluristem.com




November 13, 2014 - IMMUNE Pharmaceuticals
IMMUNE Pharmaceuticals, (NASDQ: IMNP), presented before Stock & Bond Club. Shown receiving lifetime membership award: Dr. Daniel Teper, founder and CEO of IMMUNE Pharmaceuticals & Carlo Corzine, President of The Stock & Bond Club. www.immunepharmaceuticals.com 




October 28, 2014 - iWallet
iWallet presented before Stock & Bond Club 28 October ’14. iWallet (IWAL, $0.60) presented before the Stock & Bond Club of South Florida. CEO Jack B. Chadsey outlined the companies growth and branding strategies. iWallet Corporation designs and develops security products to protect against identity, personal, and financial information theft in the United States. The company offers biometric locking wallet that protects cash, credit cards, and personal information with a proprietary fingerprint security system. The company was founded in 2009 and is headquartered in San Diego, California. www.iwalletusa.com


April 2, 2014 - Juhl Energy
Juhl Energy presented at The Stock & Bond Club on Wednesday, April 2, 2014. The Stock and Bond Club of South Florida (“SBCSF”) was pleased to host JUHL ENERGY (OTCQB:JUHL), at the Boca Raton Country Club. JUHL is a renewable energy company, specializing in Wind Power, with related interest in and offshoots into Solar and Co-Generation projects. Together with its parent, the Company has developed and operates a fleet of more than 24 wind farms and has produced predictable cash flows for 9 consecutive quarters with strong revenue diversification. In several cases, the Company had worked with Marquis-name companies and partners. JUHL is currently raising an additional $3 million of Capital at this time and it is offering a 9% yield on a New Class of Preferred stock. The SBCSF compliments JUHL’s President, John Mitola, for his excellent and informative presentation, and it appreciates JUHL subsidizing our Members’ dinner cost. We are pleased to confirm Mr. Mitola and JUHL Energy as Lifetime Members. www.juhlenergy.com


March 12, 2014 - Safeguard Scientifics
Safeguard Scientifics' John E. Shave III presented before the Stock & Bond Club of South Florida, updating the firms progress of the 19 partner portfolio companies. The shares have risen 40% since his former presentation in January ’13. www.safeguard.com


February 5, 2014 - ULURU, Inc.
Wednesday, February 5, 2014, The Stock and Bond Club of South Florida (“SBCSF”) was pleased to host ULURU, Inc., a specialty pharmaceutical company, focused on the development and marketing of innovative wound care products as our Presenter. ULURU’s products include ‘Altrazea’l, an “intelligent” powder dressing which adapts to and interacts with wounds, helps reduce or neutralize wound exudate [the cellular debris discharging from wounds] while also hydrating upon application. The company’s other major product is ‘Aphthsaol’, designed for ulcer treatment. ULURU’s products utilize its proprietary NanoFlex technology, and patent protection is extensive. SBCSF compliments ULURU’s CEO and President, Kerry Gray, for his excellent presentation, and it appreciates ULURU subsidizing our Members’ dinner cost. We are pleased to confirm Mr. Gray and ULURU as Lifetime Members of the SBCSF. President Kerry P. Gray President Kerry P. Gray President Kerry P. Gray dispays the company’s Altrazeal® powder dressing built on the Company’s Nanoflex technology. www.uluruinc.com


January 21, 2014 - Can Fite Biopharma, Lt.
The Stock & Bond Club and Irth Communications, Robert Haag present Can Fite Biopharma, Ltd.Can Fite Biopharma Ltd. presented at the Stock & Bond Club of South Florida on Tuesday, January 21st.  Pnina Fishman, Ph.D., CEO outlined the companies progress in the disease-fighting areas of Psoriasis, Rheumatiod Arthritis and Liver Cancer using compounds that target cancer and inflammatory cells. 2014 looks promising in that initial and interim phase trials will be analyzed, initiated or submitted to the US FDA. Based in Israel, Can Fite is a listed company here on the New York Stock Exchange (CANF). Dr. Fishman was bestowed an honorary member of the Stock & Bond Club by Carlo Corzine, who chaired the meeting. For further information, please visit the company’s website at www.canfite.com

 

Past Presenters


Past Presenters These are companies that have sponsored meetings since 2011:

  • Document Security Systems, Inc (DSS)

  • AV Therapeutics (private)

  • United Commodity AG

  • Careview Communications, Inc (CRVW)

  • Safeguard Scientifics (SFE)

  • MagNegas Corp (MNGE)

  • Staar Financial Advisors (Andre Weisbrod)

  • Asur Software (ASUR)

  • Meadow Bay Gold (MAYGF)

  • Paramount Gold (PZG)

  • Uranium Energy Corp (UEC)

  • Enerplus Corp (ERF)

  • CF Industries (CF)

  • Polymedix (PYMX)

  • Statoil ASA (STO)

  • BB&T Corp (BBT)

  • General Electric (GE)

  • Lexington Realty Trust (LXP)